GR850716B - - Google Patents

Info

Publication number
GR850716B
GR850716B GR850716A GR850100716A GR850716B GR 850716 B GR850716 B GR 850716B GR 850716 A GR850716 A GR 850716A GR 850100716 A GR850100716 A GR 850100716A GR 850716 B GR850716 B GR 850716B
Authority
GR
Greece
Application number
GR850716A
Other languages
Greek (el)
Inventor
Roland Dr Wenger
Rene P Dr Traber
Hans Dr Kobel
Hans Hofmann
Original Assignee
Sandoz Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB848407618A external-priority patent/GB8407618D0/en
Priority claimed from GB848411922A external-priority patent/GB8411922D0/en
Application filed by Sandoz Ag filed Critical Sandoz Ag
Publication of GR850716B publication Critical patent/GR850716B/el

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K7/00Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/64Cyclic peptides containing only normal peptide links
    • C07K7/645Cyclosporins; Related peptides
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00Antiparasitic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/02Immunomodulators
    • A61P37/06Immunosuppressants, e.g. drugs for graft rejection
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10STECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S930/00Peptide or protein sequence
    • Y10S930/01Peptide or protein sequence
    • Y10S930/19Antibiotic
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10STECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S930/00Peptide or protein sequence
    • Y10S930/01Peptide or protein sequence
    • Y10S930/27Cyclic peptide or cyclic protein

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Transplantation (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
GR850716A 1984-03-23 1985-03-21 GR850716B (US06373033-20020416-M00035.png)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB848407618A GB8407618D0 (en) 1984-03-23 1984-03-23 Organic compounds
GB848411922A GB8411922D0 (en) 1984-05-10 1984-05-10 Organic compounds

Publications (1)

Publication Number Publication Date
GR850716B true GR850716B (US06373033-20020416-M00035.png) 1985-07-19

Family

ID=26287502

Family Applications (1)

Application Number Title Priority Date Filing Date
GR850716A GR850716B (US06373033-20020416-M00035.png) 1984-03-23 1985-03-21

Country Status (24)

Country Link
US (1) US4639434A (US06373033-20020416-M00035.png)
JP (1) JPH08838B2 (US06373033-20020416-M00035.png)
AT (1) AT388737B (US06373033-20020416-M00035.png)
BE (1) BE901980A (US06373033-20020416-M00035.png)
CA (1) CA1247546A (US06373033-20020416-M00035.png)
CH (1) CH667274A5 (US06373033-20020416-M00035.png)
CS (1) CS249542B2 (US06373033-20020416-M00035.png)
DE (1) DE3509809A1 (US06373033-20020416-M00035.png)
DK (1) DK128285A (US06373033-20020416-M00035.png)
ES (1) ES8702926A1 (US06373033-20020416-M00035.png)
FI (1) FI851120L (US06373033-20020416-M00035.png)
FR (1) FR2561651B1 (US06373033-20020416-M00035.png)
GB (1) GB2155936B (US06373033-20020416-M00035.png)
GR (1) GR850716B (US06373033-20020416-M00035.png)
HU (1) HU200786B (US06373033-20020416-M00035.png)
IL (1) IL74681A (US06373033-20020416-M00035.png)
IT (1) IT1199962B (US06373033-20020416-M00035.png)
LU (1) LU85819A1 (US06373033-20020416-M00035.png)
NL (1) NL8500828A (US06373033-20020416-M00035.png)
NO (1) NO851160L (US06373033-20020416-M00035.png)
NZ (1) NZ211526A (US06373033-20020416-M00035.png)
PH (2) PH21868A (US06373033-20020416-M00035.png)
PT (1) PT80149B (US06373033-20020416-M00035.png)
SE (1) SE461334B (US06373033-20020416-M00035.png)

Families Citing this family (36)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3587505T2 (de) 1984-10-04 1994-01-05 Sandoz Ag Monoklonale antikörper gegen zyklosporine.
US4798823A (en) * 1987-06-03 1989-01-17 Merck & Co., Inc. New cyclosporin analogs with modified "C-9 amino acids"
ES2059558T3 (es) * 1987-06-17 1994-11-16 Sandoz Ag Ciclosporins y su uso como productos farmaceuticos.
EP0373260B1 (en) * 1987-06-22 1994-03-09 Merck & Co. Inc. Cyclosporin derivatives with modified "8-amino acid"
US5227467A (en) * 1987-08-03 1993-07-13 Merck & Co., Inc. Immunosuppressive fluorinated cyclosporin analogs
US4839342A (en) * 1987-09-03 1989-06-13 University Of Georgia Research Foundation, Inc. Method of increasing tear production by topical administration of cyclosporin
DE3851152T2 (de) * 1987-09-03 1995-01-26 Univ Georgia Cyclosporin-augenmittel.
US5089390A (en) * 1987-09-04 1992-02-18 Syntex (U.S.A.) Inc. 2-methyl-4-hexene- and 2-methyl-4-heptene-1,2-diol derivatives
US5236899A (en) * 1987-11-16 1993-08-17 Merck & Co., Inc. 6-position cyclosporin a analogs as modifiers of cytotoxic drug resistance
US4914188A (en) * 1987-11-16 1990-04-03 Merck & Co., Inc. Novel 6-position cyclosporin analogs as non-immunosuppressive antagonists of cyclosporin binding to cyclophilin
CH679119A5 (US06373033-20020416-M00035.png) * 1988-05-13 1991-12-31 Sandoz Ag
US4996193A (en) * 1989-03-03 1991-02-26 The Regents Of The University Of California Combined topical and systemic method of administration of cyclosporine
US5540931A (en) * 1989-03-03 1996-07-30 Charles W. Hewitt Methods for inducing site-specific immunosuppression and compositions of site specific immunosuppressants
GB8916901D0 (en) 1989-07-24 1989-09-06 Sandoz Ltd Improvements in or relating to organic compounds
US5122511A (en) * 1990-02-27 1992-06-16 Merck & Co., Inc. Immunosuppressive cyclosporin analogs with modified amino acids at position-8
US5202310A (en) * 1990-06-06 1993-04-13 Levy Gary A Cyclosporine metabolites
FI111730B (fi) * 1990-11-02 2003-09-15 Novartis Ag Menetelmä ei-immunosuppressiivisen syklosporiinin valmistamiseksi
DE69133095T2 (de) 1990-11-20 2003-03-27 Dade Behring Marburg Gmbh Cyclosporin-Immunoassay
US5747330A (en) * 1996-06-05 1998-05-05 Poli Industria Chimica Antibiotic producing microbe
KR100585348B1 (ko) 1997-10-08 2006-06-01 이소테크니카 인코포레이티드 중수소화된 시클로스포린 유사체 및 면역조절제로서 그의용도
US20030220234A1 (en) * 1998-11-02 2003-11-27 Selvaraj Naicker Deuterated cyclosporine analogs and their use as immunodulating agents
US5990274A (en) * 1997-11-25 1999-11-23 Dade Behring Inc. Cyclosporine derivatives and uses thereof
US7449544B2 (en) * 1999-11-30 2008-11-11 Cyclacel Limited p21 peptides
EP1435910B9 (en) * 2001-10-19 2010-02-03 Isotechnika Inc. Novel cyclosporin analog microemulsion preconcentrates
NZ531944A (en) 2001-10-19 2006-03-31 Isotechnika Inc Synthesis of cyclosporin analogs
AU2004222306A1 (en) * 2003-03-17 2004-09-30 Albany Molecular Research, Inc. Novel cyclosporins
US7511013B2 (en) * 2004-09-29 2009-03-31 Amr Technology, Inc. Cyclosporin analogues and their pharmaceutical uses
EP1809656A4 (en) * 2004-09-29 2009-03-25 Amr Technology Inc CYCLOSPORINAL KINANALOGA AND ITS PHARMACEUTICAL APPLICATIONS
WO2006041631A2 (en) * 2004-10-06 2006-04-20 Amr Technology, Inc. Novel cyclosporin alkynes and their utility as pharmaceutical agents
US7696166B2 (en) * 2006-03-28 2010-04-13 Albany Molecular Research, Inc. Use of cyclosporin alkyne/alkene analogues for preventing or treating viral-induced disorders
US7696165B2 (en) * 2006-03-28 2010-04-13 Albany Molecular Research, Inc. Use of cyclosporin alkyne analogues for preventing or treating viral-induced disorders
WO2008069917A2 (en) 2006-11-20 2008-06-12 Scynexis, Inc. Novel cyclic peptides
HUE042490T2 (hu) 2010-12-15 2019-07-29 Contravir Pharmaceuticals Inc 1-es és 3-as aminosav-pozícióban módosított ciklosporin analóg molekulák
CA2852056C (en) 2011-03-11 2021-08-10 Beth Israel Deaconess Medical Center, Inc. Anti-cd40 antibodies and uses thereof
CN104877013B (zh) * 2015-06-03 2018-04-20 兰州大学 环孢菌素t及其制备方法和应用
AU2016315873B2 (en) 2015-09-04 2022-08-18 Primatope Therapeutics Inc. Humanized anti-CD40 antibodies and uses thereof

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS57140753A (en) * 1981-01-09 1982-08-31 Sandoz Ag Novel cyclosporine
DE3260468D1 (en) * 1981-01-09 1984-09-06 Sandoz Ag Novel cyclosporins

Also Published As

Publication number Publication date
DK128285A (da) 1985-09-24
IT1199962B (it) 1989-01-05
NZ211526A (en) 1988-08-30
ES541465A0 (es) 1987-01-16
PT80149A (en) 1985-04-01
PH21868A (en) 1988-03-25
SE461334B (sv) 1990-02-05
IT8547852A1 (it) 1986-09-22
FR2561651A1 (fr) 1985-09-27
GB2155936A (en) 1985-10-02
IL74681A0 (en) 1985-06-30
AT388737B (de) 1989-08-25
NL8500828A (nl) 1985-10-16
JPS60215700A (ja) 1985-10-29
NO851160L (no) 1985-09-24
ATA86385A (de) 1989-01-15
CA1247546A (en) 1988-12-28
IL74681A (en) 1989-09-10
JPH08838B2 (ja) 1996-01-10
GB8507270D0 (en) 1985-04-24
GB2155936B (en) 1987-09-16
HUT38370A (en) 1986-05-28
CS249542B2 (en) 1987-03-12
CH667274A5 (de) 1988-09-30
BE901980A (fr) 1985-09-23
HU200786B (en) 1990-08-28
SE8501392L (sv) 1985-09-24
FI851120L (fi) 1985-09-24
IT8547852A0 (it) 1985-03-22
SE8501392D0 (sv) 1985-03-21
FI851120A0 (fi) 1985-03-20
DK128285D0 (da) 1985-03-21
FR2561651B1 (fr) 1990-03-09
LU85819A1 (fr) 1985-12-12
ES8702926A1 (es) 1987-01-16
US4639434A (en) 1987-01-27
PH23357A (en) 1989-07-14
DE3509809A1 (de) 1986-01-09
PT80149B (en) 1987-03-23

Similar Documents

Publication Publication Date Title
GR850716B (US06373033-20020416-M00035.png)
GR853111B (US06373033-20020416-M00035.png)
IN161580B (US06373033-20020416-M00035.png)
GR850343B (US06373033-20020416-M00035.png)
GR851785B (US06373033-20020416-M00035.png)
GR851357B (US06373033-20020416-M00035.png)
GR851415B (US06373033-20020416-M00035.png)
GR851218B (US06373033-20020416-M00035.png)
IN160899B (US06373033-20020416-M00035.png)
IN161920B (US06373033-20020416-M00035.png)
GR79505B (US06373033-20020416-M00035.png)
IN161494B (US06373033-20020416-M00035.png)
GR74648B (US06373033-20020416-M00035.png)
BG45279A1 (US06373033-20020416-M00035.png)
BG44917A1 (US06373033-20020416-M00035.png)
BG44935A1 (US06373033-20020416-M00035.png)
BG44933A1 (US06373033-20020416-M00035.png)
BG45054A1 (US06373033-20020416-M00035.png)
BG45165A1 (US06373033-20020416-M00035.png)
CA1274406C (US06373033-20020416-M00035.png)
BG45334A1 (US06373033-20020416-M00035.png)
BG45317A1 (US06373033-20020416-M00035.png)
BG45296A1 (US06373033-20020416-M00035.png)
BG45280A1 (US06373033-20020416-M00035.png)
BG45531A1 (US06373033-20020416-M00035.png)